180 related articles for article (PubMed ID: 21323470)
1. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study.
Palakurthi NK; Correa ZM; Augsburger JJ; Banerjee RK
J Ocul Pharmacol Ther; 2011 Apr; 27(2):151-6. PubMed ID: 21323470
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive evaluation of toxicity in vitreoretinal domain following insertion of sustained release methotrexate micro-implant.
Manna S; Caixeta Faraj RQ; Riemann B; Rao MB; Nair V; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK
Exp Eye Res; 2021 Apr; 205():108505. PubMed ID: 33617850
[TBL] [Abstract][Full Text] [Related]
4. Ultrasonographical assessment of implanted biodegradable device for long-term slow release of methotrexate into the vitreous.
Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Correa ZM
Exp Eye Res; 2016 Jul; 148():30-32. PubMed ID: 27181224
[TBL] [Abstract][Full Text] [Related]
5. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
[TBL] [Abstract][Full Text] [Related]
9. Investigation of kinetics of methotrexate for therapeutic treatment of intraocular lymphoma.
Palakurthi NK; Krishnamoorthy M; Augsburger JJ; Correa ZM; Banerjee RK
Curr Eye Res; 2010 Dec; 35(12):1105-15. PubMed ID: 20961217
[TBL] [Abstract][Full Text] [Related]
10. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
[TBL] [Abstract][Full Text] [Related]
11. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study.
Fialho SL; Behar-Cohen F; Silva-Cunha A
Eur J Pharm Biopharm; 2008 Mar; 68(3):637-46. PubMed ID: 17851057
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Electroretinography Assessment of Intravitreal Sustained-Release Methotrexate Microimplants in Rabbit Eyes.
Manna S; Augsburger JJ; Correa ZM; Al-Rjoub MF; Rao MB; Banerjee RK
J Ocul Pharmacol Ther; 2016 Nov; 32(9):583-594. PubMed ID: 27754738
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Toxicity Evaluation of a PLGA and Chitosan-Based Micro-Implant for Sustained Release of Methotrexate in Rabbit Vitreous.
Manna S; Donnell AM; Faraj RQC; Riemann BI; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452188
[TBL] [Abstract][Full Text] [Related]
15. Intraocular use of rituximab.
Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
[TBL] [Abstract][Full Text] [Related]
16. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
17. [A case of intraocular lymphoma having retinal adverse events associated with intravitreal methotrexate].
Kuroiwa N; Abematsu N; Matsuo Y; Nakao K; Sakamoto T
Nippon Ganka Gakkai Zasshi; 2011 Jul; 115(7):611-6. PubMed ID: 21815491
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.
Wang C; Hou H; Nan K; Sailor MJ; Freeman WR; Cheng L
Exp Eye Res; 2014 Dec; 129():74-82. PubMed ID: 25446320
[TBL] [Abstract][Full Text] [Related]
19. Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pig.
Tammewar AM; Cheng L; Hostetler KY; Falkenstein I; Beadle JR; Barron EC; Kozak I; Freeman WR
J Ocul Pharmacol Ther; 2007 Oct; 23(5):433-44. PubMed ID: 17900229
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Evaluation of Biodegradable Scleral Plug Containing Curcumin in Rabbit Eye.
Zhang J; Sun H; Zhou N; Zhang B; Ma J
Curr Eye Res; 2017 Dec; 42(12):1597-1603. PubMed ID: 29111828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
